Forbes - Vyteris is determinedly addressing three other markets for its active transdermal drug-delivery system: infertility treatment, with the development of non-injection delivery of peptide proteins, migraine treatment, and pain management. Based on the ...
- Recent posts
- Zars Pharma Withdraws Plan to Go Public
- Dutton Associates Announces Investment Opinion: Vyteris Speculative ...
- Alexander's band: Stars sing praises of pain technique
- Pain Management and Accelerated Rehabilitation for Total Hip and ...
- ReliefInsite.com: Interview with the founder of the online pain diary
- Methadone: One Pill Can Kill
- MDCH Launches New Pain And Symptom Management Website
- Local therapist focuses on relieving pain
- Bucky will go free; Snowball will get a safe home
- Free workshop to focus on back and neck pain
- Dealing with relentless pain
- Pain Management
- Pain patients at risk for sleep apnea
- St. Francis program provides relief from pain for patients
- Chronic Pain Alleviation Focus of Napa Pain Conference
- Free publication on pain and pain management
- Boston Scientific, Advanced Bionics Principals Announce Strategic
- pain management tomorrow
- What a Pain
- Integrated Pain inks contract with Coalition America